These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24413640)

  • 1. Responsiveness of dysphagia to acute L-Dopa challenge in progressive supranuclear palsy.
    Varanese S; Di Ruscio P; Ben M' Barek L; Thomas A; Onofrj M
    J Neurol; 2014 Feb; 261(2):441-2. PubMed ID: 24413640
    [No Abstract]   [Full Text] [Related]  

  • 2. Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy.
    Warnecke T; Oelenberg S; Teismann I; Hamacher C; Lohmann H; Ringelstein EB; Dziewas R
    Mov Disord; 2010 Jul; 25(9):1239-45. PubMed ID: 20629130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa-induced dystonia in a patient with possible progressive supranuclear palsy with progressive gait freezing.
    Modreanu R; Özdemir G; Buhmann C; Hauptmann B
    J Neurol Sci; 2018 May; 388():139-140. PubMed ID: 29627008
    [No Abstract]   [Full Text] [Related]  

  • 4. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A variant of the anterior opercular syndrome with supranuclear gaze palsy.
    Jadhav AP; Zenonos G; Pless M; Jovin TG; Wechsler L
    JAMA Neurol; 2013 Jun; 70(6):800-1. PubMed ID: 23753964
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progressive supranuclear palsy (PSP)].
    Nishimiya J; Yuasa T
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):45-8. PubMed ID: 10434587
    [No Abstract]   [Full Text] [Related]  

  • 7. Nortriptyline for the treatment of depression in progressive supranuclear palsy.
    Tamai S; Almeida OP
    J Am Geriatr Soc; 1997 Aug; 45(8):1033-4. PubMed ID: 9256865
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progressive supranuclear palsy, diagnostic problems in the light of own case].
    Kulczycki J; Kuran W
    Neurol Neurochir Pol; 1998; 32(6):1513-22. PubMed ID: 10358839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.
    Ling H; Massey LA; Lees AJ; Brown P; Day BL
    Brain; 2012 Apr; 135(Pt 4):1141-53. PubMed ID: 22396397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Descriptive study of a serie of patients affected by progressive supranuclear palsy].
    Villanueva-Haba VE; Garcés M; de Vera A; Valero C; Burguera JA
    Rev Neurol; 2001 Jun 1-15; 32(11):1027-30. PubMed ID: 11562823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compassionate trial of levodopa carbidopa intestinal gel infusion in two patients with progressive supranuclear palsy.
    Bhidayasiri R; Jitkritsadakul O; Boonrod N; Rerknimitr R
    Clin Neurol Neurosurg; 2014 Jan; 116():1-3. PubMed ID: 24388506
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy.
    Moccia M; Picillo M; Erro R; Allocca R; Barone P; Vitale C
    J Neurol Sci; 2015 Mar; 350(1-2):103-4. PubMed ID: 25697711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history and clinical features of progressive supranuclear palsy: a clinical study.
    Diroma C; Dell'Aquila C; Fraddosio A; Lamberti S; Mastronardi R; Russo I; De Mari M; Iliceto G
    Neurol Sci; 2003 Oct; 24(3):176-7. PubMed ID: 14598074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive supranuclear palsy.
    Kent A
    Nurs Stand; 2013 Aug 21-27; 27(51):48-57; quiz 58. PubMed ID: 23965099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tremor in progressive supranuclear palsy.
    Fujioka S; Algom AA; Murray ME; Sanchez-Contreras MY; Tacik P; Tsuboi Y; Van Gerpen JA; Uitti RJ; Rademakers R; Ross OA; Wszolek ZK; Dickson DW
    Parkinsonism Relat Disord; 2016 Jun; 27():93-7. PubMed ID: 27039056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysphagia in Progressive Supranuclear Palsy.
    Clark HM; Stierwalt JAG; Tosakulwong N; Botha H; Ali F; Whitwell JL; Josephs KA
    Dysphagia; 2020 Aug; 35(4):667-676. PubMed ID: 31676923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An assessment of dysphagia using videofluorography in Parkinson's disease and progressive supranuclear palsy].
    Ichihara N; Ichihara SI; Fujii S; Touge T; Nishioka M
    Rinsho Shinkeigaku; 2000 Nov; 40(11):1076-82. PubMed ID: 11332186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological hypersexuality induced by dopamine replacement therapy in a patient with progressive supranuclear palsy.
    Kim YY; Park HY; Kim JM; Kim KW
    J Neuropsychiatry Clin Neurosci; 2008; 20(4):496-7. PubMed ID: 19196941
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of spontaneous arm levitation in progressive supranuclear palsy.
    Gunal DI; Ağan K; Aktan S
    Neurol Sci; 2000 Dec; 21(6):405-6. PubMed ID: 11441578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excessive yawning and progressive supranuclear palsy.
    Sandyk R
    Int J Neurosci; 1987 May; 34(1-2):123-4. PubMed ID: 3610499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.